Friday, July 31, 2026

Coupang Subpoena Names South Korea’s President: Why a 34 Million-Record Data Leak Just Landed on Capitol Hill

The People Power Party criticizes President Lee's name in a U.S. subpoena, highlighting personal data leaks and diplomatic failures.

BabyMonster Thanks Fans as ‘Forever’ Dance Video Goes Behind the Scenes

YG Entertainment has unveiled the behind-the-scenes dance video for BabyMonster's latest song, "Forever."

Is Former President Yoon Seok Yeol Involved? The Shocking Truth Behind the North Korean Remittance Case

Investigations into witness coercion allegations against prosecutors in the North Korea remittance case and political manipulation continue.

Tag: Zymfentra

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Top News

- Our Sponsors Ad -

Follow us